Skip to content

A comparison of the effectiveness of prostaglandin gel and tablet preparations in induction of labour at term.

A comparison of the effectiveness of prostaglandin gel and tablet preparations in induction of labour at term.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-003797-28-GB
Enrollment
500
Registered
2005-06-13
Start date
2005-07-12
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labour

Interventions

Trade Name: Prostin (Dinoprostone) Product Name: Dinoprostone Pharmaceutical Form: Tablet for vaginal solution INN or Proposed INN: Dinoprostone CAS Number: 363-24-6 Other descriptive name: Prostaglan

Sponsors

Hammersmith Hospitals NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Term, cephalic pregnancies (all parities) undergoing prostaglandin induction of labour (all indications). Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Preterm induction of labour (ie before 37 weeks gestation)

Design outcomes

Primary

MeasureTime frame
Main Objective: To determine whether Prostaglandin Gel is more effective in term induction of labour than Prostaglandin Tablets. The main outcome measure will be time between the start of the induction process and delivery of the baby.;Secondary Objective: We also aim to determine if preparation used has any effect on several other measures during/after labour. These include mode of delivery and indication for delivery, time in labour, number of doses of prostaglandin needed, cervical dilation at transfer to labour Ward, frequency of artificial rupture of membranes, frequency of oxytocin use, frequency of meconium staining of liquor, frequency of uterine tachysystole/hyperstimulation, frequency of need for foetal blood sampling in labour, frequency of need for neonatal resuscitation or transfer to Neonatal Unit. ;Primary end point(s): Duration between start of the induction process and delivery of the baby.

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026